vs

Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and COMMERCE BANCSHARES INC (CBSH). Click either name above to swap in a different company.

Astrana Health, Inc. is the larger business by last-quarter revenue ($950.5M vs $475.7M, roughly 2.0× COMMERCE BANCSHARES INC). COMMERCE BANCSHARES INC runs the higher net margin — 29.8% vs 0.7%, a 29.1% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 11.1%). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 7.1%).

Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.

Commerce Bancshares, Inc. is a regional bank holding company headquartered in Missouri, with principal offices in Kansas City and St. Louis. It is the corporate parent of Commerce Bank, which offers a diversified line of financial services, including business and personal banking, wealth management and investments through its affiliated companies.

ASTH vs CBSH — Head-to-Head

Bigger by revenue
ASTH
ASTH
2.0× larger
ASTH
$950.5M
$475.7M
CBSH
Growing faster (revenue YoY)
ASTH
ASTH
+31.8% gap
ASTH
42.9%
11.1%
CBSH
Higher net margin
CBSH
CBSH
29.1% more per $
CBSH
29.8%
0.7%
ASTH
Faster 2-yr revenue CAGR
ASTH
ASTH
Annualised
ASTH
53.3%
7.1%
CBSH

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ASTH
ASTH
CBSH
CBSH
Revenue
$950.5M
$475.7M
Net Profit
$6.6M
$141.6M
Gross Margin
Operating Margin
1.9%
Net Margin
0.7%
29.8%
Revenue YoY
42.9%
11.1%
Net Profit YoY
184.4%
10.5%
EPS (diluted)
$0.12
$0.96

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASTH
ASTH
CBSH
CBSH
Q1 26
$475.7M
Q4 25
$950.5M
$449.4M
Q3 25
$956.0M
$441.0M
Q2 25
$654.8M
$445.8M
Q1 25
$620.4M
$428.1M
Q4 24
$665.2M
$422.1M
Q3 24
$478.7M
$421.4M
Q2 24
$486.3M
$414.5M
Net Profit
ASTH
ASTH
CBSH
CBSH
Q1 26
$141.6M
Q4 25
$6.6M
$140.7M
Q3 25
$373.0K
$141.5M
Q2 25
$9.4M
$152.5M
Q1 25
$6.7M
$131.6M
Q4 24
$-7.8M
$136.1M
Q3 24
$16.1M
$138.0M
Q2 24
$19.2M
$139.6M
Operating Margin
ASTH
ASTH
CBSH
CBSH
Q1 26
Q4 25
1.9%
40.8%
Q3 25
2.0%
41.9%
Q2 25
3.1%
44.0%
Q1 25
3.3%
39.2%
Q4 24
0.1%
41.2%
Q3 24
5.9%
42.4%
Q2 24
6.2%
43.4%
Net Margin
ASTH
ASTH
CBSH
CBSH
Q1 26
29.8%
Q4 25
0.7%
31.3%
Q3 25
0.0%
32.1%
Q2 25
1.4%
34.2%
Q1 25
1.1%
30.7%
Q4 24
-1.2%
32.2%
Q3 24
3.4%
32.8%
Q2 24
3.9%
33.7%
EPS (diluted)
ASTH
ASTH
CBSH
CBSH
Q1 26
$0.96
Q4 25
$0.12
$0.86
Q3 25
$0.01
$1.06
Q2 25
$0.19
$1.14
Q1 25
$0.14
$0.98
Q4 24
$-0.14
$0.83
Q3 24
$0.33
$1.01
Q2 24
$0.40
$1.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASTH
ASTH
CBSH
CBSH
Cash + ST InvestmentsLiquidity on hand
$429.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$779.3M
$4.3B
Total Assets
$2.2B
$35.7B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASTH
ASTH
CBSH
CBSH
Q1 26
Q4 25
$429.5M
Q3 25
$463.4M
Q2 25
$342.1M
Q1 25
$260.9M
Q4 24
$290.8M
Q3 24
$350.3M
Q2 24
$327.7M
Stockholders' Equity
ASTH
ASTH
CBSH
CBSH
Q1 26
$4.3B
Q4 25
$779.3M
$3.8B
Q3 25
$775.5M
$3.8B
Q2 25
$765.5M
$3.6B
Q1 25
$745.4M
$3.5B
Q4 24
$712.7M
$3.3B
Q3 24
$704.6M
$3.4B
Q2 24
$678.9M
$3.1B
Total Assets
ASTH
ASTH
CBSH
CBSH
Q1 26
$35.7B
Q4 25
$2.2B
$32.9B
Q3 25
$2.2B
$32.3B
Q2 25
$1.4B
$32.3B
Q1 25
$1.3B
$32.4B
Q4 24
$1.4B
$32.0B
Q3 24
$1.3B
$31.5B
Q2 24
$1.3B
$30.6B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASTH
ASTH
CBSH
CBSH
Operating Cash FlowLast quarter
$-2.9M
Free Cash FlowOCF − Capex
$-6.0M
FCF MarginFCF / Revenue
-0.6%
Capex IntensityCapex / Revenue
0.3%
Cash ConversionOCF / Net Profit
-0.44×
TTM Free Cash FlowTrailing 4 quarters
$104.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASTH
ASTH
CBSH
CBSH
Q1 26
Q4 25
$-2.9M
$645.1M
Q3 25
$10.0M
$129.0M
Q2 25
$90.9M
$111.2M
Q1 25
$16.6M
$138.6M
Q4 24
$-10.9M
$577.9M
Q3 24
$34.0M
$431.7M
Q2 24
$23.2M
$147.4M
Free Cash Flow
ASTH
ASTH
CBSH
CBSH
Q1 26
Q4 25
$-6.0M
$592.4M
Q3 25
$7.4M
$113.3M
Q2 25
$89.5M
$100.5M
Q1 25
$13.6M
$126.0M
Q4 24
$-13.5M
$531.7M
Q3 24
$31.7M
$419.1M
Q2 24
$20.4M
$138.9M
FCF Margin
ASTH
ASTH
CBSH
CBSH
Q1 26
Q4 25
-0.6%
131.8%
Q3 25
0.8%
25.7%
Q2 25
13.7%
22.5%
Q1 25
2.2%
29.4%
Q4 24
-2.0%
126.0%
Q3 24
6.6%
99.5%
Q2 24
4.2%
33.5%
Capex Intensity
ASTH
ASTH
CBSH
CBSH
Q1 26
Q4 25
0.3%
11.7%
Q3 25
0.3%
3.6%
Q2 25
0.2%
2.4%
Q1 25
0.5%
2.9%
Q4 24
0.4%
10.9%
Q3 24
0.5%
3.0%
Q2 24
0.6%
2.1%
Cash Conversion
ASTH
ASTH
CBSH
CBSH
Q1 26
Q4 25
-0.44×
4.59×
Q3 25
26.69×
0.91×
Q2 25
9.65×
0.73×
Q1 25
2.48×
1.05×
Q4 24
4.25×
Q3 24
2.11×
3.13×
Q2 24
1.21×
1.06×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASTH
ASTH

Medicare$542.4M57%
Commercial$99.1M10%
Care Delivery$92.1M10%
Care Enablement$78.9M8%
Other Third Parties$58.0M6%
Health Care Patient Service$39.8M4%
Health Care Other$25.5M3%
Other$12.1M1%
Management Service$10.3M1%

CBSH
CBSH

Segment breakdown not available.

Related Comparisons